Dermatology
Partner With Us
Advertisement
Conexiant chevron_right Dermatology chevron_right Metformin Exposure Shows Non Melanoma Skin Cancer Associations
From the Journals

Metformin Exposure Shows Non-Melanoma Skin Cancer Associations

In a study of over 12,000 cases, metformin exposure was associated with a reduced risk of both squamous and basal cell carcinomas.

Conexiant
article Full Article subject Summary summarize Notecard
  1. Metformin may be associated with a reduced risk of non-melanoma skin cancers. 
  2. The protective effect of metformin varies among demographic groups.
  3. Proposed mechanisms of metformin's protective effects include activation of AMP-activated protein kinase.
  4. Study limitations included reliance on electronic health records, potential misclassification, and lack of detailed clinical information.
  5. Further research, particularly in diverse populations, is necessary to evaluate metformin’s chemopreventive potential.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.